Back to BRISTOL MYERS SQUIBB CO

BRISTOL MYERS SQUIBB CO News

CELG-RI

Bristol-Myers Squibb Note Offering Completed (CELG-RI)

Bristol-Myers Squibb completed a multi-series note offering via subsidiary CELG-RI, issuing notes maturing 2030–2055. Report dated 2025-11-10.

10 November 2025BRISTOL MYERS SQUIBB CO
CELG-RI

Bristol-Myers $7B Note Repurchase Offer

Bristol-Myers launches $7B cash tender offers to repurchase notes. Key investor implications and context for bondholders. (2025-11-03)

3 November 2025BRISTOL MYERS SQUIBB CO
CELG-RI

Bristol Myers Squibb to Acquire Orbital Therapeutics

Bristol Myers Squibb announces acquisition of Orbital Therapeutics (Ticker: CELG-RI). Investor-focused summary and analysis — 2025-10-30.

30 October 2025BRISTOL MYERS SQUIBB CO
CELG-RI

Bristol Myers Squibb Q3 2025: $12.2B Revenue, Guidance Up

Bristol Myers Squibb Q3 2025 revenue rose 3% to $12.2B and the company raised 2025 guidance. Investor-focused summary and analysis.

30 October 2025BRISTOL MYERS SQUIBB CO
All news